Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Applied Digital Releases Fiscal Third Quarter 2026 Results AI Infrastructure Focus Continues China Industrial Profits Surge 247 in April Marking Fastest Growth in Over Two Years Baird Raises Price Target on RideNow Group Following Strong SameStore Sales Performance Texas Files Lawsuit Against Meta and WhatsApp Over Encryption Privacy Claims SafeHaven Flows Lift Swiss Franc and Japanese Yen Amid DeepSeek AI Selloff in US Tech Beneficient BENF Q1 2026 Earnings Massive EPS Beat on Positive Net Income but Shares Slide COHN Q1 2026 Earnings Profitability Surprises in a Quiet Quarter CCLDO Q1 2026 Earnings EPS Misses Estimates as Preferred Stock Holds Steady NBP Q4 2025 Earnings Significant EPS Miss Yet Stock Surges 763 IP Q1 2026 Earnings Industrial Packaging Giant Beats EPS Estimates Amid Cost Disciplines US Physical Therapy USPH Slips Slightly as Stock Consolidates Near Key Support Eaton Vance TaxManaged BuyWrite Opportunities Fund ETV Edges Higher as Income Strategy Attracts Steady Interest Radian Group Inc RDN Declines Slightly as Shares Test Key Support Levels RGC Resources Inc RGCO Slips 127 as Utility Stock Approaches Key Support Snowflake Shares Surge 36 Following Earnings Beat and 6 Billion AWS Expansion Plan UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister US Payrolls Jump More Than Expected in April but Report Reveals Underlying Economic Red Flags VS Media Holdings Expands Into AI Smart Living Sector to Unlock New Growth Avenues Tapestry Inc Holds Steady Near 139 as Traders Eye Key Levels Futu Holdings FUTU Plunges 27 Analyzing the Steep Decline and Key Levels RPM International Inc RPM Edges Higher Testing Key Resistance After 170 Gain HSBC Holdings HSBC Gains 187 as Shares Test MidRange Support WD40 Company WDFC Posts Measured Gain as Shares Approach Key Resistance Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback